UK pharma and integrated health

Louise Bellamy
12/04/2018 - 12/04/2018

The concept of integrated healthcare is not new to the UK, where it has been discussed since the late 1960s.

The difference is that now it could really happen. Technology, medicine, regulation and pricing have all evolved to a point where a collaborative, integrated system is not only possible, but desirable – and the data needed for it to become a reality is now available.

What does this mean for UK pharmaceutical companies that have historically focused on providing medicines and treatments?

On one hand there are calls for them to change – going beyond being simply a supplier of products and moving into the role of partner, sharing risk to drive great health outcomes.

On the other hand, the industry’s move into having pipelines that are largely stocked with niche products has created pricing and access questions which are yet to be fully answered.

Analysing the current situation and looking for potential routes to the future, this high-level IQVIA/pharmaphorum webinar gave an update on the latest developments and debated how pharma can be a catalyst for change at a time when the NHS is under immense pressure to cut costs and become more efficient.

Insight on these pressing issues was provided by a panel of influential healthcare experts that included former secretary of state for health, and NHS Confederation current chairman, Stephen Dorrell.

He was joined by:

  • James Roach, director, Accountable Care Partnership, West Essex Health and Care System
  • Andrew Smith, director, Cobic
  • Steve Jowett, country lead for health system engagement, IQVIA

Watch the digital debate to learn more about:

  • The evolving NHS and the STP/ICS model of delivery
  • What a collaborative future could look like
  • The role of data in the future NHS
  • Why the STP/ICS model is important for pharma

The context
Over the last few years, the government has been trying to reshape the NHS by making it more responsive to the health needs of regional populations. By dividing England’s NHS into 44 Sustainability and Transformation Partnerships (STPs), policymakers hoped to promote new care models by forging links between NHS, councils and other stakeholders.

These are now evolving into Integrated Care Systems (ICSs), involving closer collaboration between the key players, including the private sector and pharma. This system change has been controversial, with critics saying that it is tantamount to privatisation by the back door. But champions of ICSs say that it can improve governance and commissioning outcomes and create a health system that is matched to the population it serves.

The live webinar took place on Wednesday 21st March 2018 at 12:30 GMT/13:30 CET.

To listen to the webinar on demand, please click here or on the button above or below.

Participants

Rt Hon. Stephen Dorrell, Chairman of NHS Confederation, former Secretary of State for Health and Chairman of the Health Select Committee

Stephen became Chair of the NHS Confederation in November 2015.  He is also Chairman of Laing Buisson Ltd, a healthcare market intelligence company, and of its sister company Public Policy Projects Ltd which provides public policy advice.

Stephen was a Member of Parliament from 1979 to 2015 and a member of the government from 1987 to 1997, serving as a minister in the Treasury, the Department of Health and the Department of National Heritage. He was a member of the Cabinet as Secretary of State for the National Heritage from 1994 to 1995 and Secretary of State for Health from 1995 to 1997.

Stephen led Conservative Mainstream from 2001 to 2005; from 2005 to 2010 he was chair of the Conservative Public Service Improvement Group and from 2008 to 2010 he was a member of the cross-party Commission on Public Service Reform convened by the Royal Society of Arts.

Between 2010 and 2014, Stephen was the first elected chair of the House of Commons Health Committee, developing the role of the Committee as an authoritative cross-party voice on healthcare policy.

James Roach, Director, Acccountable Care Partnership, West Essex Health and Care System 

James is an experienced NHS Director having worked at a senior level in hospitals, CCGs and on a system level.  Amongst his previous roles he has been an Accountable Officer of a CCG, a Joint Director of Health and Social Care and a system wide director of transformation and integration.

James is currently shaping the development of the Accountable Care Partnership in the West Essex system and will be able to provide insights from the ground and give his view on the future direction of travel.

Andrew Smith, Director, Cobic

Andrew is a Director of Cobic. He recently led on the Department of Health’s programme for extending patient choice of Any Qualified Provider, one of the key programmes of the government’s reform agenda. Prior to this, he led the production of the ‘Procurement Guide for commissioners of NHS funded healthcare services’.

Andrew was one of the architects of the Principles and Rules for Cooperation and Competition and helped set up the Cooperation and Competition Panel to govern fairness and transparency in NHS commercial activity.

His career started in the NHS on the flagship graduate financial management training scheme (FMTS), where Andrew worked in all areas of NHS finance, qualifying as an accountant and spending two years working in a large acute trust as a divisional chief Accountant.

Steve Jowett, Country Lead for Health System Engagement, IQVIA

Stephen leads the creation of propositions and partnerships, for IQVIA across the health system and is passionate about enabling collaboration to take place that advances healthcare and improves outcomes for patients. He has led and delivered dozens of technologically enabled transformation projects at the front line of care both at IQVIA and in previous roles as deputy practice lead of Dell Services’ Healthcare Consulting Practice across EMEA. An information and business analyst by degree training, Stephen has also worked in the NHS as a business analyst and transformation lead.

Dr Paul Tunnah, CEO, pharmaphorum (moderator)

Paul Tunnah is CEO and Founder of pharmaphorum media, which facilitates productive engagement for pharma, bringing healthcare together to drive medical innovation. It combines industry-leading content and social media engagement services with the globally recognised news, information and insight portal pharmaphorum.com, working with pharmaceutical companies, service providers and broader healthcare organisations to help communicate their thought leadership and connect them with relevant stakeholders.